Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jinhai International Group Holdings Limited ( (HK:2225) ) just unveiled an update.
Jinhai Medical Technology Limited has announced that its board of directors will convene on August 29, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. This meeting will also consider the payment of an interim dividend, which could have implications for shareholders and reflect the company’s financial health and strategic direction.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the development and provision of medical products and services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 4,180,989
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$9.31B
Learn more about 2225 stock on TipRanks’ Stock Analysis page.